J-difference GABA-edited MRS reveals altered cerebello-thalamo-cortical metabolism in patients with hepatic encephalopathy.


Journal

Metabolic brain disease
ISSN: 1573-7365
Titre abrégé: Metab Brain Dis
Pays: United States
ID NLM: 8610370

Informations de publication

Date de publication:
04 2023
Historique:
received: 30 09 2022
accepted: 17 01 2023
medline: 19 4 2023
pubmed: 3 2 2023
entrez: 2 2 2023
Statut: ppublish

Résumé

Hepatic encephalopathy (HE) is a common neurological manifestation of liver cirrhosis and is characterized by an increase of ammonia in the brain accompanied by a disrupted neurotransmitter balance, including the GABAergic and glutamatergic systems. The aim of this study is to investigate metabolic abnormalities in the cerebello-thalamo-cortical system of HE patients using GABA-edited MRS and links between metabolite levels, disease severity, critical flicker frequency (CFF), motor performance scores, and blood ammonia levels. GABA-edited MRS was performed in 35 participants (16 controls, 19 HE patients) on a clinical 3 T MRI system. MRS voxels were placed in the right cerebellum, left thalamus, and left motor cortex. Levels of GABA+ and of other metabolites of interest (glutamine, glutamate, myo-inositol, glutathione, total choline, total NAA, and total creatine) were assessed. Group differences in metabolite levels and associations with clinical metrics were tested. GABA+ levels were significantly increased in the cerebellum of patients with HE. GABA+ levels in the motor cortex were significantly decreased in HE patients, and correlated with the CFF (r = 0.73; p < .05) and motor performance scores (r = -0.65; p < .05). Well-established HE-typical metabolite patterns (increased glutamine, decreased myo-inositol and total choline) were confirmed in all three regions and were closely linked to clinical metrics. In summary, our findings provide further evidence for alterations in the GABAergic system in the cerebellum and motor cortex in HE. These changes were accompanied by characteristic patterns of osmolytes and oxidative stress markers in the cerebello-thalamo-cortical system. These metabolic disturbances are a likely contributor to HE motor symptoms in HE. In patients with hepatic encephalopathy, GABA+ levels in the cerebello-thalamo-cortical loop are significantly increased in the cerebellum and significantly decreased in the motor cortex. GABA+ levels in the motor cortex strongly correlate with critical flicker frequency (CFF) and motor performance score (pegboard test tPEG), but not blood ammonia levels (NH

Identifiants

pubmed: 36729261
doi: 10.1007/s11011-023-01174-x
pii: 10.1007/s11011-023-01174-x
doi:

Substances chimiques

Glutamine 0RH81L854J
Ammonia 7664-41-7
Inositol 4L6452S749
gamma-Aminobutyric Acid 56-12-2
Choline N91BDP6H0X

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1221-1238

Subventions

Organisme : NIBIB NIH HHS
ID : R21 EB033516
Pays : United States

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Allen M, Poggiali D, Whitaker K, Marshall TR, Kievit RA (2019) Raincloud plots: a multi-platform tool for robust data visualization. Wellcome Open Res 4:63. https://doi.org/10.12688/wellcomeopenres.15191.1
doi: 10.12688/wellcomeopenres.15191.1 pubmed: 31069261 pmcid: 6480976
Barantin L, Pape AL, Akoka S (1997) A new method for absolute quantitation MRS metabolites. Magn Reson Med 38:179–182. https://doi.org/10.1002/mrm.1910380203
doi: 10.1002/mrm.1910380203 pubmed: 9256094
Barkhuijsen H, de Beer R, van Ormondt D (1987) Improved algorithm for noniterative time-domain model fitting to exponentially damped magnetic resonance signals. J Magn Reson 1969(73):553–557. https://doi.org/10.1016/0022-2364(87)90023-0
doi: 10.1016/0022-2364(87)90023-0
Baumgarten TJ, Oeltzschner G, Hoogenboom N, Wittsack H-J, Schnitzler A, Lange J (2016) Beta peak frequencies at rest correlate with endogenous GABA+/Cr concentrations in sensorimotor cortex areas. PloS One 11:e0156829. https://doi.org/10.1371/journal.pone.0156829
doi: 10.1371/journal.pone.0156829 pubmed: 27258089 pmcid: 4892568
Behar KL, Rothman DL, Petersen KF, Hooten M, Delaney R, Petroff OAC, Shulman GI, Navarro V, Petrakis IL, Charney DS, Krystal JH (1999) Preliminary evidence of low cortical gaba levels in localized 1 H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry 156:952–954. https://doi.org/10.1176/ajp.156.6.952
doi: 10.1176/ajp.156.6.952 pubmed: 10360140
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 57:289–300
Binesh N, Huda A, Bugbee M, Gupta R, Rasgon N, Kumar A, Green M, Han S, Thomas MA (2005) Adding another spectral dimension to 1H magnetic resonance spectroscopy of hepatic encephalopathy. J Magn Reson Imaging 21:398–405. https://doi.org/10.1002/jmri.20291
doi: 10.1002/jmri.20291 pubmed: 15779041
Butz M, Timmermann L, Braun M, Groiss SJ, Wojtecki L, Ostrowski S, Krause H, Pollok B, Gross J, Südmeyer M, Kircheis G, Häussinger D, Schnitzler A (2010) Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy. Acta Neurol Scand 122:27–35. https://doi.org/10.1111/j.1600-0404.2009.01246.x
doi: 10.1111/j.1600-0404.2009.01246.x pubmed: 20003084
Cao Q, Xu S, Zhu W, Zhu W, Wan Y, Wang J, Chen X, Pi L, Lobo MK, Ren B, Ying Z, Morris M (2018) Decreased taurine and creatine in the thalamus may relate tominimal hepatic encephalopathy in ethanol-fed mice using proton magnetic resonance spectroscopy. J Nucl Med 59:345–345
Cauli O, Llansola M, Erceg S, Felipo V (2006) Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra. J Hepatol 45:654–661. https://doi.org/10.1016/j.jhep.2006.06.019
doi: 10.1016/j.jhep.2006.06.019 pubmed: 16982110
Cauli O, Mansouri MT, Agusti A, Felipo V (2009a) Hyperammonemia Increases GABAergic Tone in the Cerebellum but Decreases It in the Rat Cortex. Gastroenterology 136:1359-1367.e2. https://doi.org/10.1053/j.gastro.2008.12.057
doi: 10.1053/j.gastro.2008.12.057 pubmed: 19245864
Cauli O, Rodrigo R, Llansola M, Montoliu C, Monfort P, Piedrafita B, El Mlili N, Boix J, Agustí A, Felipo V (2009b) Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab Brain Dis 24:69–80. https://doi.org/10.1007/s11011-008-9115-4
doi: 10.1007/s11011-008-9115-4 pubmed: 19085094
Choi I-Y, Andronesi OC, Barker P, Bogner W, Edden RAE, Kaiser LG, Lee P, Marjańska, M, Terpstra M, de Graaf RA (2021) Spectral editing in 1H magnetic resonance spectroscopy: experts’ consensus recommendations. NMR Biomed n/a: e4411. https://doi.org/10.1002/nbm.4411
Cichoz-Lach H, Michalak A (2013) Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. World J Gastroenterol. https://doi.org/10.3748/wjg.v19.i1.26 (Baishideng Publishing Group Inc)
Cudalbu C, Taylor-Robinson SD (2019) Brain edema in chronic hepatic encephalopathy. J Clin Exp Hepatol 9:362–382. https://doi.org/10.1016/j.jceh.2019.02.003
doi: 10.1016/j.jceh.2019.02.003 pubmed: 31360029 pmcid: 6637228
de Graaf RA (2018) In Vivo NMR Spectroscopy: Principles and Techniques, 3rd ed. Wiley. https://doi.org/10.1002/9781119382461
Edden RAE, Puts NAJ, Harris AD, Barker PB, Evans CJ (2014) Gannet: a batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra. J Magn Reson Imaging JMRI 40:1445–1452
doi: 10.1002/jmri.24478 pubmed: 25548816
Felipo V (2013) Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci 14:851–858. https://doi.org/10.1038/nrn3587
doi: 10.1038/nrn3587 pubmed: 24149188
Ferenci P, Blei AT, Lockwood AH, Mullen K, Tarter R, Weissenborn K (2002) Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, Vienna, 1998. Hepatology 35:716–721. https://doi.org/10.1053/jhep.2002.31250
doi: 10.1053/jhep.2002.31250 pubmed: 11870389
Fowler CF, Madularu D, Dehghani M, Devenyi GA, Near J (2021) Longitudinal quantification of metabolites and macromolecules reveals age- and sex-related changes in the healthy Fischer 344 rat brain. Neurobiol Aging 101:109–122. https://doi.org/10.1016/j.neurobiolaging.2020.12.012
doi: 10.1016/j.neurobiolaging.2020.12.012 pubmed: 33610061
Friston K (2007) Statistical Parametric Mapping: The Analysis of Functional Brain Images. Academic Press, Book
doi: 10.1016/B978-012372560-8/50002-4
Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG, Posse S, Jung RE, Morrison LA (2006) Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 55:1219–1226. https://doi.org/10.1002/mrm.20901
doi: 10.1002/mrm.20901 pubmed: 16688703
Hassan SS, Baumgarten TJ, Ali AM, Füllenbach N-D, Jördens MS, Häussinger D, Butz M, Schnitzler A, Groiss SJ (2019) Cerebellar inhibition in hepatic encephalopathy. Clin Neurophysiol 130:886–892. https://doi.org/10.1016/J.CLINPH.2019.02.020
doi: 10.1016/J.CLINPH.2019.02.020 pubmed: 30981173
Häussinger D, Butz M, Schnitzler A, Görg B (2021) Pathomechanisms in hepatic encephalopathy. Biol Chem 402:1087–1102. https://doi.org/10.1515/hsz-2021-0168
doi: 10.1515/hsz-2021-0168 pubmed: 34049427
Häussinger D, Dhiman RK, Felipo V, Görg B, Jalan R, Kircheis G, Merli M, Montagnese S, Romero-Gomez M, Schnitzler A, Taylor-Robinson SD, Vilstrup H (2022) Hepatic encephalopathy. Nat Rev Dis Primer 8:1–22. https://doi.org/10.1038/s41572-022-00366-6
doi: 10.1038/s41572-022-00366-6
Heaton RK (2004) Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources, Lutz, FL
Henry PG, Dautry C, Hantraye P, Bloch G (2001) Brain gaba editing without macromolecule contamination. Magn Reson Med 45:517–520. https://doi.org/10.1002/1522-2594(200103)45:3%3c517::AID-MRM1068%3e3.0.CO;2-6
doi: 10.1002/1522-2594(200103)45:3<517::AID-MRM1068>3.0.CO;2-6 pubmed: 11241712
Hermann B, Rudler M, Galanaud D, Thabut D, Weiss N (2019) Magnetic resonance spectroscopy: a surrogate marker of hepatic encephalopathy? J Hepatol 71:1055–1057. https://doi.org/10.1016/j.jhep.2019.07.008
doi: 10.1016/j.jhep.2019.07.008 pubmed: 31500856
Hilgier W, Węgrzynowicz M, Ruszkiewicz, Oja JSS, Saransaari P, Albrecht J (2010) Direct exposure to ammonia and hyperammonemia increase the extracellular accumulation and degradation of astroglia-derived glutathione in the rat prefrontal cortex. Toxicol Sci 117:163–168. https://doi.org/10.1093/toxsci/kfq171
Hui SCN, Saleh MG, Zöllner HJ, Oeltzschner G, Fan H, Li Y, Song Y, Jiang H, Near J, Lu H, Mori S, Edden RAE (2022) MRSCloud: a cloud-based MRS tool for basis set simulation. Magn Reson Med 88:1994–2004. https://doi.org/10.1002/mrm.29370
doi: 10.1002/mrm.29370 pubmed: 35775808
JAMA (2013) World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA - J Am Med Assoc 310:2191–2194. https://doi.org/10.1001/jama.2013.281053
doi: 10.1001/jama.2013.281053
Kajla N (2020) Comparison of arterial vs venous ammonia levels in hepatic encephalopathy. Ameis Curr Trends Diagn Treat 3:59–63. https://doi.org/10.5005/jp-journals-10055-0076
doi: 10.5005/jp-journals-10055-0076
Kircheis G, Häussinger D, Wettstein M, Schnitzler A, Timmermann L (2002) Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35:357–366. https://doi.org/10.1053/jhep.2002.30957
doi: 10.1053/jhep.2002.30957 pubmed: 11826409
Kircheis G, Hilger N, Häussinger D (2014) Value of Critical Flicker Frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy. Gastroenterology 146:961-969.e11. https://doi.org/10.1053/j.gastro.2013.12.026
doi: 10.1053/j.gastro.2013.12.026 pubmed: 24365582
Klose U (1990) In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 14:26–30. https://doi.org/10.1002/mrm.1910140104
doi: 10.1002/mrm.1910140104 pubmed: 2161984
Klove H (1963) Clinical neuropsychology (1963) the medical clinics of North America. FM Forster Ed 47:1647–1658
Kreis R, Farrow N, Ross BD (1991) Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 4:109–116. https://doi.org/10.1002/nbm.1940040214
doi: 10.1002/nbm.1940040214 pubmed: 1650239
Larsen RJ, Gagoski B, Morton SU, Ou Y, Vyas R, Litt J, Grant PE, Sutton BP (2021) Quantification of magnetic resonance spectroscopy data using a combined reference: application in typically developing infants. NMR Biomed. 34:e4520. https://doi.org/10.1002/nbm.4520
doi: 10.1002/nbm.4520 pubmed: 33913194
Lien Y-HH, Michaelis T, Moats RA, Ross BD (1994) Scyllo-inositol depletion in hepatic encephalopathy. Life Sci 54:1507–1512. https://doi.org/10.1016/0024-3205(94)90018-3
doi: 10.1016/0024-3205(94)90018-3 pubmed: 8190025
Lin A, Andronesi O, Bogner W, Choi I-Y, Coello E, Cudalbu C, Juchem C, Kemp GJ, Kreis R, Krššák M, Lee P, Maudsley AA, Meyerspeer M, Mlynarik V, Near J, Öz G, Peek AL, Puts NA, Ratai E-M, Tkáč I, Mullins PG, Spectroscopy EWG, on R.S. for M., (2021) Minimum Reporting Standards for in vivo Magnetic Resonance Spectroscopy (MRSinMRS): experts’ consensus recommendations. NMR Biomed. 34:e4484. https://doi.org/10.1002/nbm.4484
doi: 10.1002/nbm.4484 pubmed: 33559967 pmcid: 8647919
Lockwood AH (2004) Blood ammonia levels and hepatic encephalopathy. Metab Brain Dis 19:345–349. https://doi.org/10.1023/B:MEBR.0000043980.74574.eb
doi: 10.1023/B:MEBR.0000043980.74574.eb pubmed: 15554426
Lockwood AH, Yap EW, Wong WH (1991) Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 11:337–341. https://doi.org/10.1038/jcbfm.1991.67
doi: 10.1038/jcbfm.1991.67
Mallet M, Desplats V, Bouzbib C, Sultanik P, Alioua I, Rudler M, Weiss N, Thabut D (2022) Blood ammonia in patients with chronic liver diseases: a better defined role in clinical practice. Anal. Biochem 657:114873. https://doi.org/10.1016/j.ab.2022.114873
doi: 10.1016/j.ab.2022.114873 pubmed: 36108794
Menshchikov P, Ivantsova A, Manzhurtsev A, Ublinskiy M, Yakovlev A, Melnikov I, Kupriyanov D, Akhadov T, Semenova N (2020) Separate N-acetyl aspartyl glutamate, N-acetyl aspartate, aspartate, and glutamate quantification after pediatric mild traumatic brain injury in the acute phase. Magn Reson Med 84:2918–2931. https://doi.org/10.1002/mrm.28332
doi: 10.1002/mrm.28332 pubmed: 32544309
Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R (1998) Simultaneous in vivo spectral editing and water suppression. NMR Biomed 11:266–272. https://doi.org/10.1002/(SICI)1099-1492(199810)11:6%3c266::AID-NBM530%3e3.0.CO;2-J
doi: 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J pubmed: 9802468
Michels L, Schulte-Vels T, Schick M, O’Gorman RL, Zeffiro T, Hasler G, Mueller-Pfeiffer C (2014) Prefrontal GABA and glutathione imbalance in posttraumatic stress disorder: preliminary findings. Psychiatry Res Neuroimaging 224:288–295. https://doi.org/10.1016/j.pscychresns.2014.09.007
doi: 10.1016/j.pscychresns.2014.09.007
Miller JJ, Cochlin L, Clarke K, Tyler DJ (2017) Weighted averaging in spectroscopic studies improves statistical power. Magn Reson Med 78:2082–2094. https://doi.org/10.1002/mrm.26615
doi: 10.1002/mrm.26615 pubmed: 28127795 pmcid: 5697704
Murthy CRK, Bender AS, Dombro RS, Bai G, Norenberg MD (2000) Elevation of glutathione levels by ammonium ions in primary cultures of rat astrocytes. Neurochem Int 37:255–268. https://doi.org/10.1016/S0197-0186(00)00028-0
doi: 10.1016/S0197-0186(00)00028-0 pubmed: 10812211
Near J, Edden RAE, Evans CJ, Paquin R, Harris AD, Jezzard P (2015) Frequency and phase drift correction of magnetic resonance spectroscopy data by spectral registration in the time domain. Magn Reson Med 73:44–50. https://doi.org/10.1002/mrm.25094
doi: 10.1002/mrm.25094 pubmed: 24436292
Near J, Harris AD, Juchem C, Kreis R, Marjańska M, Öz G, Slotboom J, Wilson M, Gasparovic C (2020) Preprocessing, analysis and quantification in single-voxel magnetic resonance spectroscopy: experts’ consensus recommendations. NMR Biomed. 34:e4257. https://doi.org/10.1002/nbm.4257
doi: 10.1002/nbm.4257 pubmed: 32084297 pmcid: 7442593
Oeltzschner G, Butz M, Baumgarten TJ, Hoogenboom N, Wittsack H-J, Schnitzler A (2015) Low visual cortex GABA levels in hepatic encephalopathy: links to blood ammonia, critical flicker frequency, and brain osmolytes. Metab Brain Dis 30:1429–1438. https://doi.org/10.1007/s11011-015-9729-2
doi: 10.1007/s11011-015-9729-2 pubmed: 26359122
Oeltzschner G, Butz M, Wickrath F, Wittsack H-J, Schnitzler A (2016) Covert hepatic encephalopathy: elevated total glutathione and absence of brain water content changes. Metab Brain Dis 31:517–527. https://doi.org/10.1007/s11011-015-9760-3
doi: 10.1007/s11011-015-9760-3 pubmed: 26563124
Oeltzschner G, Saleh MG, Rimbault D, Mikkelsen M, Chan KL, Puts NAJ, Edden RAE (2019) Advanced Hadamard-encoded editing of seven low-concentration brain metabolites: principles of HERCULES. Neuroimage 185:181–190. https://doi.org/10.1016/j.neuroimage.2018.10.002
doi: 10.1016/j.neuroimage.2018.10.002 pubmed: 30296560
Oeltzschner G, Zöllner HJ, Hui SCN, Mikkelsen M, Saleh MG, Tapper S, Edden RAE (2020) Osprey: open-source processing, reconstruction & estimation of magnetic resonance spectroscopy data. J Neurosci Methods 343:108827. https://doi.org/10.1016/j.jneumeth.2020.108827
doi: 10.1016/j.jneumeth.2020.108827 pubmed: 32603810 pmcid: 7477913
Palmieri L, Pardo B, Lasorsa FM, del Acro A, Kobayashi K, Iijima M, Runswick MJ, Walker JE, Saheki T, Satrústegui J, Palmieri F (2001) Citrin and aralar1 are Ca2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 20:5060–5069. https://doi.org/10.1093/emboj/20.18.5060
doi: 10.1093/emboj/20.18.5060 pubmed: 11566871 pmcid: 125626
Pasek J (2021) Weights: weighting and weighted statistics (manual) [WWW Document]. https://cran.r-project.org/web/packages/weights/index.html . Accessed 28 Apr 2021
Petroff OAC, Hyder F, Rothman DL, Mattson RH (2001) Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 42:543–548. https://doi.org/10.1046/j.1528-1157.2001.18800.x
doi: 10.1046/j.1528-1157.2001.18800.x pubmed: 11440351
Prakash R, Mullen KD (2010) Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 7:515–525. https://doi.org/10.1038/nrgastro.2010.116
doi: 10.1038/nrgastro.2010.116 pubmed: 20703237
Provencher S (2020) LCModel & LCMgui User’s Manual [WWW Document]. LCModel LCMgui Users Man. URL http://s-provencher.com/pub/LCModel/manual/manual.pdf . Accessed 28 April 2020
Provencher SW (2001) Automatic quantitation of localized in vivo1H spectra with LCModel. NMR Biomed 14:260–264. https://doi.org/10.1002/nbm.698
doi: 10.1002/nbm.698 pubmed: 11410943
Rae CD (2014) A guide to the metabolic pathways and function of metabolites observed in human brain 1 H magnetic resonance spectra. Neurochem Res 39:1–36
doi: 10.1007/s11064-013-1199-5 pubmed: 24258018
Rao KVR, Norenberg MD (2001) Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia. Metab Brain Dis 16:67–78. https://doi.org/10.1023/A:1011666612822
doi: 10.1023/A:1011666612822 pubmed: 11726090
Rothman DL, Petroff OA, Behar KL, Mattson RH (1993) Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci 90:5662–5666. https://doi.org/10.1073/pnas.90.12.5662
doi: 10.1073/pnas.90.12.5662 pubmed: 8516315 pmcid: 46781
Sathyasaikumar KV, Swapna I, Reddy PVB, Murthy ChRK, Dutta Gupta A, Senthilkumaran B, Reddanna P (2007) Fulminant hepatic failure in rats induces oxidative stress differentially in cerebral cortex, cerebellum and pons medulla. Neurochem Res 32:517–524. https://doi.org/10.1007/s11064-006-9265-x
doi: 10.1007/s11064-006-9265-x pubmed: 17268843
Schafer DF, Anthony Jones E (1982) Hepatic encephalopathy and the γ-aminobutyric-acid neurotransmitter system. The Lancet 319:18–20. https://doi.org/10.1016/S0140-6736(82)92559-4
doi: 10.1016/S0140-6736(82)92559-4
Shah NJ, Neeb H, Kircheis G, Engels P, Häussinger D, Zilles K (2008) Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage 41:706–717. https://doi.org/10.1016/j.neuroimage.2008.02.057
doi: 10.1016/j.neuroimage.2008.02.057 pubmed: 18456518
Shah NJ, Neeb H, Zaitsev M, Steinhoff S, Kircheis G, Amunts K, Häussinger D, Zilles K (2003) Quantitative T1Mapping of hepatic encephalopathy using magnetic resonance imaging. Hepatology 38:1219–1226. https://doi.org/10.1053/jhep.2003.50477
doi: 10.1053/jhep.2003.50477 pubmed: 14578860
Simicic D, Cudalbu C, Pierzchala K (2022) Overview of oxidative stress findings in hepatic encephalopathy: from cellular and ammonium-based animal models to human data. Anal Biochem 654:114795. https://doi.org/10.1016/j.ab.2022.114795
doi: 10.1016/j.ab.2022.114795 pubmed: 35753389
Simpson R, Devenyi GA, Jezzard P, Hennessy TJ, Near J (2015) Advanced processing and simulation of MRS data using the FID appliance (FID-A)—An open source, MATLAB-based toolkit. Magn Reson Med 77:23–33. https://doi.org/10.1002/mrm.26091
doi: 10.1002/mrm.26091 pubmed: 26715192
Singhal A, Nagarajan R, Hinkin CH, Kumar R, Sayre J, Elderkin-Thompson V, Huda A, Gupta RK, Han S-H, Thomas MA (2010) Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo. J Magn Reson Imaging 32:35–43. https://doi.org/10.1002/jmri.22216
doi: 10.1002/jmri.22216 pubmed: 20578008
Stagg CJ, Bachtiar V, Johansen-Berg H (2011) What are we measuring with GABA magnetic resonance spectroscopy? Commun Integr Biol 4:573–575. https://doi.org/10.4161/cib.4.5.16213
doi: 10.4161/cib.4.5.16213 pubmed: 22046466 pmcid: 3204132
Terpstra M, Henry P-G, Gruetter R (2003) Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn Reson Med 50:19–23. https://doi.org/10.1002/mrm.10499
doi: 10.1002/mrm.10499 pubmed: 12815674
Thoma R, Mullins P, Ruhl D, Monnig M, Yeo RA, Caprihan A, Bogenschutz M, Lysne P, Tonigan S, Kalyanam R, Gasparovic C (2011) Perturbation of the glutamate-glutamine system in alcohol dependence and remission. Neuropsychopharmacology 36:1359–1365. https://doi.org/10.1038/npp.2011.20
doi: 10.1038/npp.2011.20 pubmed: 21389979 pmcid: 3096805
Timmermann L, Gross J, Butz M, Kircheis G, Häussinger D, Schnitzler A (2003) Mini-asterixis in hepatic encephalopathy induced by pathologic thalamo-motor-cortical coupling. Neurology 61:689–692. https://doi.org/10.1212/01.WNL.0000078816.05164.B1
doi: 10.1212/01.WNL.0000078816.05164.B1 pubmed: 12963765
Viola A, Nicoli F, Denis B, Confort-Gouny S, Fur YL, Ranjeva J-P, Viout P, Cozzone PJ (2004) High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism. Magn Reson Mater Phys Biol Med 17:47–61. https://doi.org/10.1007/s10334-004-0044-x
doi: 10.1007/s10334-004-0044-x
Węgrzynowicz M, Hilgier W, Dybel A, Oja SS, Saransaari P, Albrecht J (2007) Upregulation of cerebral cortical glutathione synthesis by ammonia in vivo and in cultured glial cells: the role of cystine uptake. Neurochem Int Mechanisms Neurodegeneration 50:883–889. https://doi.org/10.1016/j.neuint.2006.12.003
doi: 10.1016/j.neuint.2006.12.003
Wijtenburg SA, Knight-Scott J (2011) Very short echo time improves the precision of glutamate detection at 3T in 1H magnetic resonance spectroscopy. J Magn Reson Imaging 34:645–652. https://doi.org/10.1002/jmri.22638
doi: 10.1002/jmri.22638 pubmed: 21761460
Wilson M, Andronesi O, Barker PB, Bartha R, Bizzi A, Bolan PJ, Brindle KM, Choi I-Y, Cudalbu C, Dydak U, Emir UE, Gonzalez RG, Gruber S, Gruetter R, Gupta RK, Heerschap A, Henning A, Hetherington HP, Huppi PS, Hurd RE, Kantarci K, Kauppinen RA, Klomp DWJ, Kreis R, Kruiskamp MJ, Leach MO, Lin AP, Luijten PR, Marjańska M, Maudsley AA, Meyerhoff DJ, Mountford CE, Mullins PG, Murdoch JB, Nelson SJ, Noeske R, Öz G, Pan JW, Peet AC, Poptani H, Posse S, Ratai E-M, Salibi N, Scheenen TWJ, Smith ICP, Soher BJ, Tkáč I, Vigneron DB, Howe FA (2019) Methodological consensus on clinical proton MRS of the brain: review and recommendations. Magn Reson Med 82:527–550. https://doi.org/10.1002/mrm.27742
doi: 10.1002/mrm.27742 pubmed: 30919510 pmcid: 7179569
Zeng G, Penninkilampi R, Chaganti J, Montagnese S, Brew BJ, Danta M (2020) Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy. Neurology 94:e1147–e1156. https://doi.org/10.1212/WNL.0000000000008899
doi: 10.1212/WNL.0000000000008899 pubmed: 31919113
Zöllner HJ, Butz M, Jördens M, Füllenbach N-D, Häussinger D, Schmitt B, Wittsack H-J, Schnitzler A (2019) Chemical exchange saturation transfer imaging in hepatic encephalopathy. NeuroImage Clin 22:101743. https://doi.org/10.1016/j.nicl.2019.101743
doi: 10.1016/j.nicl.2019.101743 pubmed: 30856541 pmcid: 6411782
Zöllner HJ, Butz M, Kircheis G, Klinker S, Häussinger D, Schmitt B, Schnitzler A, Wittsack H-J (2018) Ammonia-weighted imaging by chemical exchange saturation transfer MRI at 3 T. NMR Biomed. 31:e3947. https://doi.org/10.1002/nbm.3947
doi: 10.1002/nbm.3947 pubmed: 29975436
Zöllner HJ, Považan M, Hui SCN, Tapper S, Edden RAE, Oeltzschner G (2021a) Comparison of different linear-combination modeling algorithms for short-TE proton spectra. NMR Biomed 34:e4482. https://doi.org/10.1002/nbm.4482
doi: 10.1002/nbm.4482 pubmed: 33530131 pmcid: 8935349
Zöllner HJ, Tapper S, Hui SCN, Barker PB, Edden RAE, Oeltzschner G (2021b) Comparison of linear combination modeling strategies for edited magnetic resonance spectroscopy at 3 T. NMR Biomed: e4618. https://doi.org/10.1002/nbm.4618

Auteurs

Helge Jörn Zöllner (HJ)

Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. hzoelln2@jh.edu.
F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA. hzoelln2@jh.edu.
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. hzoelln2@jh.edu.
Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. hzoelln2@jh.edu.

Thomas A Thiel (TA)

Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Nur-Deniz Füllenbach (ND)

Department of Gastroenterology, Hepatology and Infectiology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Markus S Jördens (MS)

Department of Gastroenterology, Hepatology and Infectiology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Sinyeob Ahn (S)

Siemens Healthcare, San Francisco, CA, USA.

Lena M Wilms (LM)

Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Alexandra Ljimani (A)

Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Dieter Häussinger (D)

Department of Gastroenterology, Hepatology and Infectiology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Markus Butz (M)

Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Hans-Jörg Wittsack (HJ)

Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Alfons Schnitzler (A)

Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Georg Oeltzschner (G)

Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH